Vertex Pharmaceuticals (VRTX) is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Prices have rallied from early October to a high in early April. A correction has unfolded the past six weeks or so giving us the opportunity to potentially profit from the next trend.
More from Investing
We failed to get an oversold bounce and the major headwind continues to be interest rates.
Advanced Micro Devices' shares have been cut in half this year but that has not motivated investors to become buyers. Let's check the charts to see how low it can go.
Here we'll look at the newest anti-ESG fund, the upcoming God Bless America ETF, and why agnostic investing is the best kind.
FDX will likely continue to weigh on the broader averages.